Co-Authors
This is a "connection" page, showing publications co-authored by Katrien Lagrou and Paul Verweij.
Connection Strength
0.963
-
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021 08; 47(8):819-834.
Score: 0.238
-
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020 Aug; 46(8):1524-1535.
Score: 0.222
-
Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients. J Antimicrob Chemother. 2019 09 01; 74(9):2759-2766.
Score: 0.210
-
Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: A comparative multicenter study. Med Mycol. 2020 Jun 01; 58(4):444-452.
Score: 0.055
-
Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus. J Antimicrob Chemother. 2018 08 01; 73(8):2274.
Score: 0.049
-
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018 10; 6(10):782-792.
Score: 0.049
-
Triazole resistance surveillance in Aspergillus fumigatus. Med Mycol. 2018 Apr 01; 56(suppl_1):83-92.
Score: 0.048
-
Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus. J Antimicrob Chemother. 2017 Dec 01; 72(12):3325-3333.
Score: 0.047
-
Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus. mSphere. 2017 Jul-Aug; 2(4).
Score: 0.046